Body Pharm Kisspeptin 10
R700.00R600.00On sale
SKU bpkisp10v
Body Pharm Kisspeptin 10, supplied lyophilised and third-party assayed for purity and identity. Cold-chain handled and shipped discreetly from South Africa. Certificate of analysis available on request.
Card · EFT · Bitcoin · Discreet delivery
Body Pharm Kisspeptin 10 is a 10 mg lyophilised research peptide. We dispatch orders the same day if payment clears before 12:00 on a business day. This item, with the unique stock-keeping unit (SKU) bpkisp10v, is available for delivery within South Africa via a tracked courier service.
| Attribute | Body Pharm Kisspeptin 10 |
|---|---|
| Brand | Body Pharm |
| SKU | bpkisp10v |
| Stated strength | 10 mg |
| Format | Lyophilised powder |
| Availability | InStock |
| Delivery | South Africa only; major metros next business day, outlying areas 2–5 working days |
We claim every batch undergoes third-party testing for purity and identity. You can access the Certificate of Analysis (CoA) for a specific batch on the product page or by requesting it via email. Review the batch-specific CoA before you buy to verify this claim applies to your vial. Our stated handling process uses cold-chain storage and dispatch; confirm at checkout if a gel pack is included with this specific product.
Always check the live product page for the current price and listing before completing your payment.
Why buyers check the batch documentation
A Certificate of Analysis provides the stated identity and purity results for the specific batch you intend to purchase. We state that each batch is tested by a third party and that the CoA is available on the product page or by email request. This documentation typically lists the batch number, test date, testing laboratory, and the results for identity and purity. It does not confirm the product is safe for human use, effective for any condition, or registered with the South African Health Products Regulatory Authority (SAHPRA). We advise requesting the CoA before purchasing to match the document to your batch.
If you compare options, view Body Pharm DSIP 5 or our full wellness and recovery peptides category.
What this product page does not establish
This product listing and its associated claims do not constitute South African regulatory authorisation. As of 21 October 2026, no publicly available SAHPRA record confirms Kisspeptin-10 as a registered or authorised medicine in South Africa. The claims we make, about third-party testing, CoA availability, and cold-chain handling, are our own. They are not independent verification that a batch meets regulatory standards for human consumption.
Scientific context and regulatory status
Current scientific literature, such as a 2026 study involving three healthy men, shows that continuous intravenous Kisspeptin-10 can increase luteinising hormone levels. However, this small, clinically supervised study does not validate the safety, efficacy, or appropriate dosage of a 10 mg lyophilised vial sold online. Recent research primarily focuses on anti-doping detection methods, not approved consumer treatments.
SAHPRA's guidance from 30 October 2025 clarifies that selling unregistered medicines without prior authorisation is not permitted. A research-use disclaimer does not automatically grant regulatory compliance. This listing should not be interpreted as encouragement to self-prescribe, inject, or treat any medical condition. For health-related questions, consult a qualified medical professional.
Merchant claims versus regulatory status
| Claim on this page | What it does NOT prove |
|---|---|
| Wording like "research use" | Compliance with SAHPRA regulations or an exemption from medicine registration. |
| CoA available on request | That your specific vial was tested or that results meet clinical safety thresholds. |
| Cold-chain handling | That the product requires or maintains stability through refrigeration during transit. |
| The listed price | That the price will remain valid beyond the date shown on the live product page. |
Browse wellness and recovery peptides to compare compounds, or shop the full South African range.
Sources
- Category A – Unregistered Products, SAHPRA, 23 July 2026
- Guideline for Section 21 Access to Unregistered Medicines, SAHPRA, 30 October 2025
- Peptide Products – Public Information, SAHPRA, 26 May 2026
- Detection of kisspeptin-10 in urine using LC high-resolution mass spectrometry, PubMed, 8 July 2024
- Dynamic modulation of LH secretion by continuous kisspeptin infusion in healthy men, PubMed, 2 June 2026
- Kisspeptin Administration Stimulates Reproductive Hormones but Does Not Affect Anxiety in Humans, PubMed, 16 October 2025